During the past decade, Carolina Urology Partners conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 6 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carolina Urology Partners" #1 sponsor was "Dendreon" with 3 trials, followed by "Coloplast A/S" with 2 trials sponsored, "Allergan" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "GenomeDx Biosciences Corp" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carolina Urology Partners" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator, "Society of Urologic Oncology (SUO)" with 1 trials as a collaborator and "Syntactx" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Carolina Urology Partners" are "Prostate Cancer" (3 trials), "Stress Urinary Incontinence" (3 trials), "Advanced Prostate Cancer" (1 trials), "Cancer of the Prostate" (1 trials) and "Castration-Resistant Prostate Cancer" (1 trials). Many other conditions were trialed in "Carolina Urology Partners" in a lesser frequency.

Most popular intervention types in "Carolina Urology Partners" are "Biological" (3 trials), "Device" (3 trials), "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Altis Sling" (1 trials), "Altis® Single Incision Sling System (SIS)" (1 trials), "Decipher" (1 trials), "Enzalutamide" (1 trials) and "Macroplastique" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carolina Urology Partners" are 5 trials for "Male" genders, 4 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Carolina Urology Partners". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Carolina Urology Partners, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Carolina Urology Partners, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".